Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.

[1]  R. Barazzoni,et al.  Defining and diagnosing sarcopenia: Is the glass now half full? , 2023, Metabolism: clinical and experimental.

[2]  D. Volkert,et al.  Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022. , 2023, Clinical nutrition.

[3]  H. Van Remmen,et al.  Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia , 2022, Antioxidants.

[4]  Yun Li,et al.  Sarcopenic Obesity: An Emerging Public Health Problem , 2022, Aging and disease.

[5]  Qian-yi Zhou,et al.  Circulating acyl and des-acyl ghrelin levels in obese adults: a systematic review and meta-analysis , 2022, Scientific Reports.

[6]  D. Volkert,et al.  Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. , 2022, Clinical nutrition.

[7]  G. Muscogiuri,et al.  Sarcopenic obesity: What about in the cancer setting? , 2022, Nutrition.

[8]  Alessandra P. Mulder,et al.  Sarcopenia and poor muscle quality associated with severe obesity in young adults and middle-aged adults. , 2021, Clinical nutrition ESPEN.

[9]  M. Rizzo,et al.  Exploring the Role of Skeletal Muscle in Insulin Resistance: Lessons from Cultured Cells to Animal Models , 2021, International journal of molecular sciences.

[10]  Yi Shang,et al.  Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis. , 2021, Clinical nutrition.

[11]  Wei-liang Chen,et al.  Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan , 2021, British Journal of Nutrition.

[12]  Yuxiang Sun.  Thrifty Hormone Ghrelin: The Secret of Aging Muscularly , 2020, Journal of aging science.

[13]  M. Muscaritoli,et al.  Both ghrelin deletion and unacylated ghrelin overexpression preserve muscles in aging mice , 2020, Aging.

[14]  K. Nair,et al.  Higher unacylated ghrelin and insulin sensitivity following dietary restriction and weight loss in obese humans. , 2020, Clinical nutrition.

[15]  J. Atkins,et al.  Sarcopenic obesity in ageing: cardiovascular outcomes and mortality , 2020, British Journal of Nutrition.

[16]  K. Choi,et al.  Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences , 2020, International journal of molecular sciences.

[17]  Ho‐Seong Han,et al.  Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. , 2019, Clinical nutrition.

[18]  Andy S. K. Cheng,et al.  Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis , 2019, BMC Geriatrics.

[19]  R. Barazzoni,et al.  Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals. , 2019, Clinical nutrition.

[20]  Guoyao Wu,et al.  Protective effects of ghrelin on fasting-induced muscle atrophy in aging mice. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  Duck-chul Lee,et al.  Muscular Strength as a Predictor of All-Cause Mortality in an Apparently Healthy Population: A Systematic Review and Meta-Analysis of Data From Approximately 2 Million Men and Women. , 2018, Archives of physical medicine and rehabilitation.

[22]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[23]  J. Batsis,et al.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies , 2018, Nature Reviews Endocrinology.

[24]  A. Van Gossum,et al.  Sarcopenic Obesity: Time to Meet the Challenge , 2018, Obesity Facts.

[25]  E. Nisoli,et al.  Insulin resistance in obesity: an overview of fundamental alterations , 2018, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

[26]  M. Giacca,et al.  Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Benoit Smeuninx,et al.  Age-Related Anabolic Resistance of Myofibrillar Protein Synthesis Is Exacerbated in Obese Inactive Individuals , 2017, The Journal of clinical endocrinology and metabolism.

[28]  S. Paluska,et al.  Anabolic sensitivity of postprandial muscle protein synthesis to the ingestion of a protein-dense food is reduced in overweight and obese young adults. , 2016, The American journal of clinical nutrition.

[29]  M. Giacca,et al.  Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance. , 2016, Clinical nutrition.

[30]  M. Giacca,et al.  Unacylated Ghrelin Reduces Skeletal Muscle Reactive Oxygen Species Generation and Inflammation and Prevents High-Fat Diet–Induced Hyperglycemia and Whole-Body Insulin Resistance in Rodents , 2016, Diabetes.

[31]  G. Sergi,et al.  Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. , 2015, Clinical nutrition.

[32]  R. Situlin,et al.  The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index – Results from the North-East Italy MoMa Population Study , 2014, PloS one.

[33]  A. J. van der Lely,et al.  Des-acyl ghrelin: a metabolically active peptide. , 2013, Endocrine development.

[34]  Richard W. Bohannon,et al.  Hand Grip Strength: age and gender stratified normative data in a population-based study , 2011, BMC Research Notes.

[35]  S. Walrand,et al.  Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. , 2009, The Journal of clinical endocrinology and metabolism.

[36]  I. Janssen,et al.  Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. , 2009, The American journal of clinical nutrition.

[37]  B. Ciocchi,et al.  Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[38]  M. Papotti,et al.  Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[39]  Robert Ross,et al.  Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.

[40]  G. Frost,et al.  Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[41]  M. Nakazato,et al.  A role for ghrelin in the central regulation of feeding , 2001, Nature.

[42]  K. Kangawa,et al.  Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. , 2000, Biochemical and biophysical research communications.

[43]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[44]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[45]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[46]  I. Idris,et al.  Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis , 2015, Diabetologia.